Ginkgo Bioworks Holdings, Inc. (DNA) Ownership
DNA ownership summary
as of October 18, 2026- Institutions
- 73.8% of shares outstanding
- Insiders
- 4.43% of shares outstanding
- Shares outstanding
- 55.4M
- Float
- 49.9M shares available to trade
- Short interest
- 13.64% 7.3M shares short
- Days to cover
- 3.90 short interest up 6.6% vs prior month
- Institutions 73.78%
- Insiders 4.43%
- Other investors 21.79%
DNA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 6.36% | 4.3M | $44.0M | +640,556 (+17.6%) | June 30, 2026 |
| 2 | Viking Global Investors LP | 5.31% | 3.6M | $36.7M | — | June 30, 2026 |
| 3 | Erste Asset Management GmbH | 3.77% | 2.5M | $26.1M | +589,211 (+30.3%) | June 30, 2026 |
| 4 | Baillie Gifford & Co Limited. | 3.55% | 2.4M | $24.6M | — | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 3.10% | 2.1M | $21.4M | +172,865 (+9.0%) | June 30, 2026 |
| 6 | Anchorage Advisors, LLC | 2.59% | 1.7M | $17.9M | — | June 30, 2026 |
| 7 | Legal & General Group PLC | 2.48% | 1.7M | $17.1M | +7,832 (+0.5%) | June 30, 2026 |
| 8 | State Street Corp | 2.19% | 1.5M | $15.1M | +125,711 (+9.3%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 1.81% | 1.2M | $12.6M | +212,654 (+21.1%) | June 30, 2026 |
| 10 | Forbes J M & Co | 1.48% | 1000K | $10.3M | −28,480 (−2.8%) | June 30, 2026 |
| 11 | Vanguard Portfolio Management, LLC | 1.39% | 938K | $9.6M | +372,151 (+65.8%) | June 30, 2026 |
| 12 | Allianz Asset Management AG | 1.17% | 786K | $8.1M | +85,282 (+12.2%) | June 30, 2026 |
| 13 | UBS Group AG | 1.03% | 692K | $7.1M | +108,860 (+18.7%) | June 30, 2026 |
| 14 | Millennium Management LLC | 0.95% | 639K | $6.6M | +150,719 (+30.9%) | June 30, 2026 |
| 15 | AQR Capital Management LLC | 0.92% | 622K | $6.4M | +326,837 (+110.9%) | June 30, 2026 |
| 16 | SB INVESTMENT ADVISERS (UK) LTD | 0.91% | 611K | $6.3M | — | June 30, 2026 |
| 17 | The Goldman Sachs Group Inc | 0.90% | 607K | $6.2M | −322,486 (−34.7%) | June 30, 2026 |
| 18 | Bank of America Corp | 0.81% | 546K | $5.6M | +68,939 (+14.5%) | June 30, 2026 |
| 19 | Prescott Group Capital Management LLC | 0.80% | 542K | $5.6M | — | June 30, 2026 |
| 20 | Renaissance Technologies Corp | 0.80% | 540K | $5.5M | +439,400 (+437.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 3.3M shares and 2 cut 351K.
DNA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Scottish Mortgage Ord | 3.55% | 2.4M | $24.6M | — | July 31, 2026 |
| 2 | L&G Artificial Intelligence ETF | 2.66% | 1.8M | $18.4M | −4,422 (−0.2%) | September 30, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 2.21% | 1.5M | $15.3M | — | August 31, 2026 |
| 4 | iShares Russell 2000 ETF | 1.87% | 1.3M | $12.9M | −14,528 (−1.1%) | September 30, 2026 |
| 5 | Fidelity Small Cap Index | 0.78% | 523K | $5.4M | +6,381 (+1.2%) | July 31, 2026 |
| 6 | PIMCO RAE US Small Instl | 0.75% | 506K | $5.2M | +16,940 (+3.5%) | June 30, 2026 |
| 7 | iShares Russell 2000 Value ETF | 0.67% | 449K | $4.6M | +680 (+0.2%) | September 30, 2026 |
| 8 | Robo Global® Artificial Intelligence ETF | 0.61% | 408K | $4.2M | +3,996 (+1.0%) | September 30, 2026 |
| 9 | iShares Biotechnology ETF | 0.56% | 378K | $3.9M | −2,864 (−0.8%) | September 30, 2026 |
| 10 | Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 0.48% | 325K | $3.3M | — | September 30, 2026 |
| 11 | Vanguard Russell 2000 ETF | 0.41% | 273K | $2.8M | +5,400 (+2.0%) | August 31, 2026 |
| 12 | Schwab US Small-Cap ETF™ | 0.40% | 270K | $2.8M | +180 (+0.1%) | September 30, 2026 |
| 13 | Vanguard Explorer Inv | 0.37% | 251K | $2.6M | +98,445 (+64.3%) | June 30, 2026 |
| 14 | Fidelity Extended Market Index | 0.37% | 250K | $2.6M | −8,419 (−3.3%) | August 31, 2026 |
| 15 | Vanguard Strategic Small-Cap Equity Inv | 0.35% | 235K | $2.4M | +198,686 (+554.2%) | June 30, 2026 |
| 16 | Invesco RAFI US 1500 Small-Mid ETF | 0.25% | 167K | $1.7M | — | September 30, 2026 |
| 17 | iShares Micro-Cap ETF | 0.22% | 150K | $1.5M | −1,036 (−0.7%) | September 30, 2026 |
| 18 | iShares Genomics Immnlgy & Hlthcr ETF | 0.18% | 124K | $1.3M | +3,432 (+2.8%) | September 30, 2026 |
| 19 | Vanguard Health Care ETF | 0.18% | 123K | $1.3M | +9,344 (+8.2%) | August 31, 2026 |
| 20 | Schwab Small Cap Index | 0.17% | 116K | $1.2M | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
DNA insider transactions
latest 16| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-17 | Steven P Coen | Sell | $7.95 | 324 | $2,576 |
| 2026-04-13 | Steven P Coen | Sell | $6.41 | 33,171 | $212,626 |
| 2026-04-10 | Barry Canton | Sell | $6.43 | 124,727 | $801,995 |
| 2026-04-10 | Reshma P Shetty | Sell | $6.43 | 124,727 | $801,995 |
| 2026-04-09 | Barry Canton | Sell | $6.40 | 13,116 | $83,942 |
| 2026-04-09 | Jason R Kelly | Sell | $6.40 | 109,767 | $702,509 |
| 2026-04-09 | Reshma P Shetty | Sell | $6.40 | 13,116 | $83,942 |
| 2026-04-08 | Barry Canton | Sell | $6.93 | 13,155 | $91,164 |
| 2026-04-08 | Jason R Kelly | Sell | $6.93 | 97,015 | $672,314 |
| 2026-04-08 | Reshma P Shetty | Sell | $6.93 | 13,155 | $91,164 |
| 2026-03-16 | Steven P Coen | Sell | $6.74 | 708 | $4,772 |
| 2026-01-20 | Steven P Coen | Sell | $8.92 | 972 | $8,670 |
| 2025-12-15 | Steven P Coen | Sell | $8.89 | 736 | $6,543 |
| 2025-10-17 | Steven P Coen | Sell | $13.65 | 1,312 | $17,909 |
| 2025-10-01 | Steven P Coen | Sell | $15.00 | 5,609 | $84,135 |
| 2025-07-17 | Steven P Coen | Sell | $9.84 | 1,084 | $10,667 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
DNA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns DNA
Institutional investors own 73.8% of Ginkgo Bioworks's shares and insiders 4.43%. The largest holder is BlackRock Inc with 6.36% of the shares (4.3M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 2 reduced their stake in the latest filings. Short interest is 13.64% of the float, or 3.90 days of average trading volume. The share count rose 91.2% since 2019.
Related: DNA analyst forecast, DNA key metrics. See the DNA stock overview for the latest quote and news.
DNA ownership FAQ
Who owns the most Ginkgo Bioworks stock?
The largest shareholders of Ginkgo Bioworks are BlackRock Inc (6.36%), Viking Global Investors LP (5.31%), Erste Asset Management GmbH (3.77%), Baillie Gifford & Co Limited. (3.55%), Vanguard Capital Management, LLC (3.10%).
What percentage of Ginkgo Bioworks is owned by institutions?
Institutions hold 73.8% of Ginkgo Bioworks's shares outstanding; insiders hold 4.43%.
Which funds own Ginkgo Bioworks?
The largest fund holders of Ginkgo Bioworks are Scottish Mortgage Ord (3.55%), L&G Artificial Intelligence ETF (2.66%), Vanguard MStar Total Stk Mkt Idx Invest (2.21%), iShares Russell 2000 ETF (1.87%), Fidelity Small Cap Index (0.78%).
What is Ginkgo Bioworks's short interest?
7.3M shares of Ginkgo Bioworks were sold short, 13.64% of the float; at the average daily volume it would take 3.90 days to cover.
Are insiders buying or selling Ginkgo Bioworks?
Of the latest 16 reported insider transactions in Ginkgo Bioworks (since July 17, 2025), 0 were purchases and 16 were sales.
How many shares of Ginkgo Bioworks are outstanding?
Ginkgo Bioworks has 55.4M shares outstanding, of which 49.9M are in the public float.